National Health Investors Stock Fundamentals
| WX6 Stock | 73.50 1.50 2.08% |
National Health Investors fundamentals help investors to digest information that contributes to National Health's financial success or failures. It also enables traders to predict the movement of National Stock. The fundamental analysis module provides a way to measure National Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to National Health stock.
National |
National Health Investors Company Net Income Analysis
National Health's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current National Health Net Income | 66.4 M |
Most of National Health's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, National Health Investors is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, National Health Investors reported net income of 66.4 M. This is much higher than that of the sector and significantly higher than that of the Net Income industry. The net income for all Germany stocks is notably lower than that of the firm.
National Health Investors Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining National Health's current stock value. Our valuation model uses many indicators to compare National Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across National Health competition to find correlations between indicators driving National Health's intrinsic value. More Info.National Health Investors is rated below average in current valuation category among its peers. It also is rated below average in price to book category among its peers . The ratio of Current Valuation to Price To Book for National Health Investors is about 1,825,784,077 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the National Health's earnings, one of the primary drivers of an investment's value.National Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses National Health's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of National Health could also be used in its relative valuation, which is a method of valuing National Health by comparing valuation metrics of similar companies.National Health is currently under evaluation in net income category among its peers.
National Fundamentals
| Current Valuation | 3.32 B | |||
| Price To Book | 1.82 X | |||
| Price To Sales | 8.98 X | |||
| Revenue | 278.19 M | |||
| EBITDA | 178.82 M | |||
| Net Income | 66.4 M | |||
| Total Debt | 1.15 B | |||
| Cash Flow From Operations | 185.34 M | |||
| Market Capitalization | 2.24 B | |||
| Total Asset | 2.51 B | |||
| Z Score | 0.6 | |||
| Annual Yield | 0.09 % | |||
| Net Asset | 2.51 B |
About National Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze National Health Investors's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of National Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of National Health Investors based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for National Stock Analysis
When running National Health's price analysis, check to measure National Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy National Health is operating at the current time. Most of National Health's value examination focuses on studying past and present price action to predict the probability of National Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move National Health's price. Additionally, you may evaluate how the addition of National Health to your portfolios can decrease your overall portfolio volatility.